Map Home
Type / to search with text or keywords
/
keyboard shortcut: Type "/" on your keyboard for a quick search
Search button
Loading...
Loading...
Scroll left
Grants
Citations
H-Index
Patents
News
Books
Scroll right
Collapse sidebar
Data issues & feedback
Adjust height of sidebar
KMap
Grant
Adjust height of sidebar
KMap
Grant
Pharmacodynamic Effects and Predictive Biomarkers of JAK/STAT Inhibition with Ruxolitinib in Operable Head and Neck Cancer: A Window Trial
Sponsored by University of California, San Francisco
Active
$142.1K Funding
1 People
External
Related Topics
pharmacodynamics,
biomarkers,
jak/stat inhibition,
head and neck cancer,
clinical trial
People
Steven Wang
Principal Investigator (PI)
Otolaryngology
﹒Chair
